Mark T Esser

13PUBLICATIONS
158CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsInnate immunityGene and molecular therapyMedical infection agents (incl. prions)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 28, 2025
Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escape.

Fangqiang Zhu, Saravanan Rajan, Conor F Hayes

|Jan 30, 2025
Pre-exposure antibody prophylaxis protects macaques from severe influenza.

Masaru Kanekiyo, Rebecca A Gillespie, Kristine Cooper

|Jun 26, 2024
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults.

Yingyun Cai, Seme Diallo, Kim Rosenthal

|Jul 12, 2023
Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients.

Julio Diaz Caballero, Rachel M Wheatley, Natalia Kapel

|Jan 23, 2023
Safety, Tolerability and Pharmacokinetics of Half-Life Extended Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab-Cilgavimab) in Healthy Adults.

Pablo Forte-Soto, Muna Albayaty, Dennis Brooks

|Dec 21, 2022
A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine.

Lauren A Chang, Emily Phung, Michelle C Crank

Pageof 3

Frequent Collaborators

5 joint publications

Yueh-Ming Loo

3 joint publications

James E Crowe

2 joint publications

Lily I Cheng

2 joint publications

Thomas Van der Schalk